- Marketwired•4 days ago
Akers Biosciences, Inc. , , a developer of rapid health information technologies, today announces the closing of its previously announced underwritten public offering of 1,667,000 shares of common stock ...
- American City Business Journals•6 days ago
A South Jersey company that makes rapid screening and diagnostic testing products is looking to raise $2 million in a public stock sale. Akers Biosciences Inc. of Thorofare, New Jersey, is selling just under 1.7 million shares of common stock and five-year warrants to purchase up to 833,500 shares of common stock at a combined public offering price of $1.20 per share and half-warrant.
- 24/7 Wall St.•7 days ago
Considering the new Trump administration, there is an increasingly positive sentiment in the health care sector. In the past year, the health care sector was in trouble under fire from congressional hearings ...
AKR.L : Summary for AKERS BIOSCIENCES, INC. COM SHS - Yahoo Finance
Akers Biosciences, Inc. (AKR.L)
LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
|Bid||120.00 x 120000|
|Ask||135.00 x 120000|
|Day's Range||120.00 - 120.00|
|52 Week Range||80.00 - 255.00|
|PE Ratio (TTM)||-111.11|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|